Pediatric Studies: Industry Seeks Narrower, More Timely Requests From US FDA
Executive Summary
PhRMA asks FDA to consider expiration of pediatric exclusivity in requesting pediatric clinical trials; AbbVie describes eight-year effort to begin enrollment in Humira pediatric ulcerative colitis study.
You may also be interested in...
Pediatric Study Plans For Coronavirus Therapies To Get Trans-Atlantic Streamlining
EMA and US FDA offer sponsors help in completing their pediatric study plan templates and identifying areas of overlap between the two agencies requirements.
Decentralized Clinical Trials Among Topics Slated For CDER Guidance In 2020
US FDA's to-do list also includes guidances on development of non-opioid analgesics and cannabis compounds, evaluation of generic therapeutic equivalence, and pediatric product development.
Full Pediatric Labeling Is Lacking For One Third Of Orphan Drugs, US FDA Finds
The past three years have seen an increase in number of orphan drug labels containing appropriate pediatric information.